In vivo and in vitro effects of cytokines and the hemoregulatory peptide dimer (pEEDCK)2 (pyroGlu-Glu-Asp-Cys-Lys)2 on Gα16-positive hematopoiesis

[1]  R. Schulte‐Hermann,et al.  Activated granulocytes oxidize the endogenous stem cell inhibitory peptide pGlu-Glu-Asp-Cys-Lys (pEEDCK) to the stimulatory dimer: a redox-mediated mechanism for demand-induced hematopoietic regulation. , 1998, Experimental hematology.

[2]  M. Pfeilstöcker,et al.  Monitoring of hematopoietic recovery after autologous stem cell transplantation by analysis of G alpha 16 mRNA and CD34 surface glycoprotein , 1998, Annals of Hematology.

[3]  Xin-Yun Huang,et al.  Direct stimulation of Bruton's tyrosine kinase by Gq-protein α-subunit , 1997, Nature.

[4]  S. Hermouet,et al.  Specific expression of heterotrimeric G proteins G12 and G16 during human myeloid differentiation. , 1997, Experimental hematology.

[5]  T. Lion,et al.  Debate round-table. Appropriate controls for RT-PCR. , 1997, Leukemia.

[6]  S. Ralston,et al.  Control genes for reverse-transcription-polymerase chain reaction: a comparison of beta actin and glyceraldehyde phosphate dehydrogenase. , 1997, British journal of haematology.

[7]  D. Goldenberg,et al.  Reduction in the duration of myelotoxicity associated with radioimmunotherapy with infusions of the hemoregulatory peptide, HP5b in mice , 1997, International journal of cancer.

[8]  M. Pfeilstöcker,et al.  Expression of G alpha 16, a G-protein alpha subunit specific for hematopoiesis in acute leukemia. , 1996, Leukemia.

[9]  S. Ferrari,et al.  Interleukin‐11 (IL‐11) acts as a synergistic factor for the proliferation of human myeloid leukaemic cells , 1995, British journal of haematology.

[10]  W. Paukovits,et al.  Stem cell stimulation in vitro by the dekapeptide (pEEDCK)2: a single-factor alternative for multifactor cocktails. , 1995, Leukemia.

[11]  Dianqing Wu,et al.  Selective Coupling of β2-Adrenergic Receptor to Hematopoietic-specific G Proteins (*) , 1995, The Journal of Biological Chemistry.

[12]  B. Dörken,et al.  G protein subunit G alpha 16 expression is restricted to progenitor B cells during human B-cell differentiation. , 1995, Blood.

[13]  N. Qian,et al.  Expression of GTPase-deficient G alpha 16 inhibits Swiss 3T3 cell growth. , 1994, Journal of Biological Chemistry.

[14]  E. Wintersberger,et al.  Different regulation of thymidine kinase during the cell cycle of normal versus DNA tumor virus-transformed cells. , 1994, The Journal of biological chemistry.

[15]  M. Simon,et al.  Activation of phospholipase C beta 4 by heterotrimeric GTP-binding proteins. , 1994, The Journal of biological chemistry.

[16]  Melvin I. Simon,et al.  G protein-coupled signal transduction pathways for interleukin-8. , 1993, Science.

[17]  M. Simon,et al.  Specific interactions of chemoattractant factor receptors with G-proteins. , 1993, The Journal of biological chemistry.

[18]  O. Laerum,et al.  Adherent-cell-dependent stimulation of CFU-GM by nucleobases, nucleosides, their analogues, and the hemoregulatory peptide dimer. , 1992, Experimental hematology.

[19]  M. Simon,et al.  G alpha 16, a G protein alpha subunit specifically expressed in hematopoietic cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[20]  D. Huhn,et al.  Multiparameter flow‐cytometrical quantitation of circulating CD34+‐cells: correlation to the quantitation of circulating haemopoietic progenitor cells by in vitro colony‐assay , 1991, British journal of haematology.

[21]  R. Schulte‐Hermann,et al.  Hemoregulatory peptide pGlu-Glu-Asp-Cys-Lys: a new synthetic derivative for avoiding dimerization and loss of inhibitory activity. , 1990, Molecular pharmacology.

[22]  R. Schulte‐Hermann,et al.  Prevention of hematotoxic side effects of cytostatic drugs in mice by a synthetic hemoregulatory peptide. , 1990, Cancer research.

[23]  D. Tenen,et al.  Regulation of the gene for CD34, a human hematopoietic stem cell antigen, in KG-1 cells. , 1990, Blood.